echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Bidding for non base drugs in Jiangxi Province is about to start, and the bidding group transmits the signal of tightening

    Bidding for non base drugs in Jiangxi Province is about to start, and the bidding group transmits the signal of tightening

    • Last Update: 2014-05-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: asidake news agency of wisdom 2014-05-05 Jiangxi non base drug bidding is about to start At the end of the week, the drug procurement center of Jiangxi Province issued a notice to supplement the bidding catalogue of drugs at and above the county level, preliminarily stipulated the bidding grouping of the bidding catalogue, and restricted high-quality varieties such as independent pricing, high quality and good price According to the notice, those with two or more independent pricing or high quality and good price in the same bidding group will not be grouped separately, that is to say, if there are more than two aforementioned varieties in one bidding group, these varieties will not enjoy the treatment of higher quality level and can only compete with other production enterprises in price A number of front-line people engaged in Jiangxi bidding confirmed to the big wisdom news agency, which is stricter than the signal sent out in the previous draft A senior industry person told the big smart news agency that the final plan of Jiangxi may be quite different from the draft issued at the beginning of this year, and the overall plan may be more strict Because the previous draft was too mild, it caused a lot of disputes, such as the original research, the new version of GMP and the quality level division of imported drugs At the end of January this year, Jiangxi Province publicly solicited opinions on drug bidding schemes at and above the county level From the provisions of drug price limit, quality level division, double envelope evaluation method and other aspects, the industry generally believed that it was more rational However, in the process of soliciting opinions, there was a multi-party interest game A person close to the drug bidding Office of the province previously revealed that Jiangxi's most concerned modification was the division of the original research drug level  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.